Molecular Neurobiology

, Volume 55, Issue 5, pp 4127–4135 | Cite as

TRPV4 Activation Contributes Functional Recovery from Ischemic Stroke via Angiogenesis and Neurogenesis

  • Chun-Kai Chen
  • Po-Yuan Hsu
  • Tzu-Ming Wang
  • Zhi-Feng Miao
  • Ruey-Tay Lin
  • Suh-Hang H. Juo
Article

Abstract

The endothelial transient receptor potential cation channel subfamily V member 4 (TRPV4) plays a crucial role in vascular remodeling; however, TRPV4-mediated angiogenesis after ischemic neuronal death as a neurorestorative strategy has not yet been thoroughly examined. In this study, we first tested whether TRPV4 activation can improve functional recovery in rats subjected to transient brain ischemia. The possible mechanisms for TRPV4 activation-promoted functional recovery were explored. A TRPV4 agonist, 4α-phorbol 12,13-didecanoate (4α-PDD), was intravenously injected via the tail vein at 6 h and 1, 2, 3, 4 days after ischemic stroke. The treatment reduced infarct volume by almost 50% (14.7 ± 3.7 vs. 29.2 ± 6.2%; p < 0.0001) and improved functional outcomes (p = 0.03) on day 5. To explore the therapeutic mechanism, we measured endothelial nitric oxide synthase (eNOS) expression and phosphorylation, vascular endothelial growth factor A (VEGFA) signaling, and neural stem/progenitor cells (NPCs). TRPV4 activation significantly increased eNOS expression and phosphorylation (serine 1177) by more than 2-fold in the ischemic region. The expressions of VEGFA and VEGF receptor-2 were significantly higher in the treated animals, especially an increase of the proangiogenic VEGFA164a isoform while a decrease of the antiangiogenic VEGFA165b isoform. We evaluated angiogenesis by detecting microvessel density in ischemic region. Using the immunohistochemistry staining, we found that 4α-PDD treatment caused a 3.4-fold increase of microvessel density (p < 0.0001). In addition, NPC proliferation and migration in the ischemic hemisphere were increased by 3-fold and 5-fold, respectively. In conclusion, our data suggest that TRPV4 activation by 4α-PDD may improve poststroke functional improvement through angiogenesis and neurogenesis.

Keywords

TRPV4 Nitric oxide synthase Angiogenesis Neurogenesis Ischemic stroke 

Abbreviations

4α-PDD

4α-Phorbol 12,13-didecanoate

BBB

Blood–brain barrier

EPCs

Endothelial progenitor cells

ECs

Endothelial cells

FSS

Fluid shear stress

GS

Garcia score

eNOS

Endothelial nitric oxide synthase

NPCs

Neural stem/progenitor cells

NO

Nitric oxide

SVZ

Subventricular zone

tMCAO

Transient middle carotid artery occlusion

TRPV4

Transient receptor potential vanilloid 4

VEGFA

Vascular endothelial growth factor A

VEGFR2

VEGF receptor-2

Notes

Acknowledgements

We thank JY. Wang (Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University) for technical support. This work was supported by the following funding: Ministry of Science and Technology (Taiwan, R.O.C.; MOST 103-2314-B-075-076-MY3, MOST 104-2745-B-037-001, MOST 105-2314-B-039-050, MOST 103-2314-B-037-027-MY2) and National Health Research Institutes (Taiwan, R.O.C.; NHRI-EX106-10605PI).

Compliance with Ethical Standards

All experimental procedures were approved by the Institutional Animal Ethical Committee Kaohsiung Medical University and were conducted according to the Guide for the Care and Use of Laboratory Animal of the National Institute of Health.

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

12035_2017_625_Fig7_ESM.gif (15 kb)
Supplementary Fig. 1

Schematic illustration of the experimental design. Transient middle cerebral artery occlusion (tMCAO) was inducted by 2-h occlusion in right internal carotid artery. 4a-phorbol-12,13-didecanoate (4α-PDD) was used as an agonist for endothelial transient receptor potential vanilloid 4.* represents the test points for neurological deficits score (NDS). ** represents the test points for infarct volume. # represents the test points for Garcia score (GS). (GIF 15 kb)

12035_2017_625_MOESM1_ESM.tif (77 kb)
High resolution image (TIFF 76 kb)
12035_2017_625_Fig8_ESM.gif (35 kb)
Supplementary Fig. 2

Delayed deaths are not observed with 4α-PDD treatment. Mortality was assessed during 5 d after tMCAO in 4α-PDD group (n = 23), and control group (treated with DMSO, n = 26). Mortality at day 5 was not significantly different. (GIF 34 kb)

12035_2017_625_MOESM2_ESM.tif (207 kb)
High resolution image (TIFF 206 kb)
12035_2017_625_MOESM3_ESM.docx (13 kb)
Supplementary Table S1 (DOCX 13 kb)
12035_2017_625_MOESM4_ESM.docx (14 kb)
Supplementary Table S2 (DOCX 14 kb)

References

  1. 1.
    Mozaffarian D, Benjamin EJ, Go AS et al (2016) Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:e38–e360CrossRefPubMedGoogle Scholar
  2. 2.
    Meyer S, Verheyden G, Brinkmann N et al (2015) Functional and motor outcome 5 years after stroke is equivalent to outcome at 2 months: Follow-up of the collaborative evaluation of rehabilitation in stroke across Europe. Stroke 46:1613–1619CrossRefPubMedGoogle Scholar
  3. 3.
    Cowman S, Royston M, Hickey A et al (2010) Stroke and nursing home care: a national survey of nursing homes. BMC Geriatr 10:4CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Teng H, Zhang ZG, Wang L et al (2008) Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab 28:764–771CrossRefPubMedGoogle Scholar
  5. 5.
    Zhang ZG, Chopp M (2009) Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491–500CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kahle MP, Bix GJ (2013) Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential. Neurorehabil Neural Repair 27:469–478CrossRefPubMedGoogle Scholar
  7. 7.
    Everaerts W, Nilius B, Owsianik G (2010) The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol 103:2–17CrossRefPubMedGoogle Scholar
  8. 8.
    Troidl C, Troidl K, Schierling W et al (2009) Trpv4 induces collateral vessel growth during regeneration of the arterial circulation. J Cell Mol Med 13:2613–2621CrossRefPubMedGoogle Scholar
  9. 9.
    Zaninetti R, Fornarelli A, Ciarletta M et al (2011) Activation of TRPV4 channels reduces migration of immortalized neuroendocrine cells. J Neurochem 116:606–615CrossRefPubMedGoogle Scholar
  10. 10.
    Hatano N, Suzuki H, Itoh Y et al (2013) TRPV4 partially participates in proliferation of human brain capillary endothelial cells. Life Sci 92:317–324CrossRefPubMedGoogle Scholar
  11. 11.
    Randhawa PK, Jaggi AS (2015) TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection. Eur J Pharmacol 746:180–185CrossRefPubMedGoogle Scholar
  12. 12.
    Dragoni S, Guerra G, Fiorio Pla A et al (2015) A functional transient receptor potential vanilloid 4 (TRPV4) channel is expressed in human endothelial progenitor cells. J Cell Physiol 230:95–104CrossRefPubMedGoogle Scholar
  13. 13.
    Schmidt W, Endres M, Dimeo F et al (2013) Train the vessel, gain the brain: physical activity and vessel function and the impact on stroke prevention and outcome in cerebrovascular disease. Cerebrovasc Dis 35:303–312CrossRefPubMedGoogle Scholar
  14. 14.
    Liu J, Wang Y, Akamatsu Y et al (2014) Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. Prog Neurobiol 115:138–156CrossRefPubMedGoogle Scholar
  15. 15.
    Schierling W, Troidl K, Apfelbeck H et al (2011) Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel. Eur J Vasc Endovasc Surg 41:589–596CrossRefPubMedGoogle Scholar
  16. 16.
    Wragg JW, Durant S, McGettrick HM et al (2014) Shear stress regulated gene expression and angiogenesis in vascular endothelium. Microcirculation 21:290–300CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang L, Hu X, Luo J et al (2013) Physical exercise improves functional recovery through mitigation of autophagy, attenuation of apoptosis and enhancement of neurogenesis after MCAO in rats. BMC Neurosci 14:1CrossRefGoogle Scholar
  18. 18.
    Ke Z, Yip S, Li L et al (2011) The effects of voluntary, involuntary, and forced exercises on brain-derived neurotrophic factor and motor function recovery: a rat brain ischemia model. PLoS One 6:e16643CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Zhu J, Song W, Li L et al (2016) Endothelial nitric oxide synthase: a potential therapeutic target for cerebrovascular diseases. Mol Brain 9:30CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Gertz K, Endres M (2008) eNOS and stroke: prevention, treatment and recovery. Future Neurol 3:537–550CrossRefGoogle Scholar
  21. 21.
    Gao Y, Zhao Y, Pan J et al (2014) Treadmill exercise promotes angiogenesis in the ischemic penumbra of rat brains through caveolin-1/VEGF signaling pathways. Brain Res 1585:83–90CrossRefPubMedGoogle Scholar
  22. 22.
    Mac Gabhann F, Qutub AA, Annex BH et al (2010) Systems biology of pro-angiogenic therapies targeting the VEGF system. Wiley Interdiscip Rev Syst Biol Med 2:694–707CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Rajagopalan S, Mohler ER, Lederman RJ et al (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108:1933–1938CrossRefPubMedGoogle Scholar
  24. 24.
    Kikuchi R, Nakamura K, MacLauchlan S et al (2014) An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nat Med 20:1464–1471CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Harper SJ, Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880–887CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Sawada M, Sawamoto K (2013) Mechanisms of neurogenesis in the normal and injured adult brain. Keio J Med 62:13–28CrossRefPubMedGoogle Scholar
  27. 27.
    Saha B, Peron S, Murray K et al (2013) Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury. Stem Cell Res 11:965–977CrossRefPubMedGoogle Scholar
  28. 28.
    Christie KJ, Turnley AM (2013) Regulation of endogenous neural stem/progenitor cells for neural repair-factors that promote neurogenesis and gliogenesis in the normal and damaged brain. Front Cell Neurosci 6:70CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Carreira BP, Morte MI, Inácio  et al (2010) Nitric oxide stimulates the proliferation of neural stem cells bypassing the epidermal growth factor receptor. Stem Cells 28:1219–1230PubMedGoogle Scholar
  30. 30.
    Zhang RL, Zhang Z, Zhang L et al (2006) Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res 83:1213–1219CrossRefPubMedGoogle Scholar
  31. 31.
    Chen J, Zacharek A, Zhang C et al (2005) Endothelial nitric oxide synthase regulates brain derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25:2366–2375CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Jie P, Lu Z, Hong Z et al (2016) Activation of transient receptor potential vanilloid 4 is involved in neuronal injury in middle cerebral artery occlusion in mice. Mol Neurobiol 53:8–17CrossRefPubMedGoogle Scholar
  33. 33.
    Li L, Qu W, Zhou L et al (2013) Activation of transient receptor potential vanilloid 4 increases NMDA-activated current in hippocampal pyramidal neurons. Front Cell Neurosci 7:17PubMedPubMedCentralGoogle Scholar
  34. 34.
    Navaratna D, Guo S, Arai K et al (2009) Mechanisms and targets for angiogenic therapy after stroke. Cell Adhes Migr 3:216–223CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Chun-Kai Chen
    • 1
    • 2
  • Po-Yuan Hsu
    • 3
  • Tzu-Ming Wang
    • 3
  • Zhi-Feng Miao
    • 4
  • Ruey-Tay Lin
    • 5
  • Suh-Hang H. Juo
    • 3
    • 6
    • 7
    • 8
    • 9
  1. 1.Department of Physical Medicine and RehabilitationKaohsiung Medical University HospitalKaohsiungTaiwan
  2. 2.Graduate Institute of Medicine, Collage of MedicineKaohsiung Medical UniversityKaohsiungTaiwan
  3. 3.Department of Medical ResearchChina Medical University HospitalTaichungTaiwan
  4. 4.Division of Colorectal Surgery, Department of SurgeryKaohsiung Medical University HospitalKaohsiungTaiwan
  5. 5.Department of NeurologyKaohsiung Medical University HospitalKaohsiungTaiwan
  6. 6.Graduate Institute of Biomedical SciencesChina Medical UniversityTaichungTaiwan
  7. 7.Institute of New Drug DevelopmentChina Medical UniversityTaichungTaiwan
  8. 8.Brain Disease Research CenterChina Medical UniversityTaichungTaiwan
  9. 9.Center for Myopia and Eye DiseaseChina Medical UniversityTaichungTaiwan

Personalised recommendations